Gene: KCNMB3
Official Full Name: potassium calcium-activated channel subfamily M regulatory beta subunit 3provided by HGNC
Gene Summary: MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta subunit. The protein encoded by this gene is an auxiliary beta subunit which may partially inactivate or slightly decrease the activation time of MaxiK alpha subunit currents. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 22. [provided by RefSeq, Jul 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07510 | KCNMB3 Knockout cell line (HeLa) | Human | KCNMB3 | 1:3~1:6 | Negative | Online Inquiry |
KO07511 | KCNMB3 Knockout cell line (A549) | Human | KCNMB3 | 1:3~1:4 | Negative | Online Inquiry |
KCNMB3 Gene Knockout Cell Lines are engineered cellular models that provide a powerful tool for studying the function of the KCNMB3 gene, which encodes a beta subunit of the calcium-activated potassium channels. These cell lines are generated through precise gene editing techniques, such as CRISPR/Cas9, resulting in a complete knockout of KCNMB3 expression. By eliminating the normal function of this gene, researchers can investigate the physiological and pathological roles of the KCNMB3 protein in cellular processes, such as membrane excitability, muscle contraction, and neuronal signaling.
The core mechanism behind these knockout cell lines lies in their ability to elucidate the impact of KCNMB3 deficiency on potassium ion currents and cellular responses. By employing electrophysiological techniques, scientists can assess how the absence of this channel component alters calcium-dependent responses within the cellular environment. This information is invaluable for exploring its involvement in cardiovascular diseases, neurodegenerative disorders, and other conditions linked to ion channel dysregulation.
KCNMB3 Gene Knockout Cell Lines are not only pivotal in academic research but also have significant implications in translational medicine. They can aide in the identification of novel therapeutic targets, enabling the development of pharmaceutical agents that can modulate calcium-activated potassium channels for disease treatment. Compared to conventional cellular models, these knockout cell lines offer a higher level of specificity and control, thus enhancing the reliability of experimental outcomes.
For researchers and clinicians, the value of KCNMB3 Gene Knockout Cell Lines is evident in their potential to streamline experimental designs while yielding robust data that translates into real-world applications. With our expertise in biotechnology and commitment to advancing scientific discovery, we provide meticulously validated cell lines, ensuring quality and consistency in every batch. Our product offerings are designed to empower the scientific community in unlocking new therapeutic avenues and understanding the complexities of gene regulation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.